VivoSeq
Other

Hemodynamic Stability

2

Pipeline Programs

4

Active Trials

2

Companies Involved

Hemodynamic Stability is an early-stage landscape with 2 programs across 2 companies. The most active players are Haisco Pharmaceutical Group Co., Ltd., Fresenius Kabi Oncology Ltd.. 2 therapies are approved.

Pipeline Metrics

Competitive Density

24/100

Pipeline Velocity

15/100

Mech. Concentration

100/100

Completion Rate

79/100

Attrition Rate

16/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs

Trial Status

19

clinical trials

Completed11 · 58%
Not yet recruiting3 · 16%
Withdrawn2 · 11%
Enrolling by invitation1 · 5%
Terminated1 · 5%
Unknown status1 · 5%

Trial Activity

19 trials

Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)